Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma

J Hepatol. 2006 Dec;45(6):805-12. doi: 10.1016/j.jhep.2006.07.025. Epub 2006 Sep 22.

Abstract

Background/aims: The hepatitis B virus (HBV) genotype C is associated with the development of hepatocellular carcinoma (HCC). In addition, the HBV X gene, which encodes the pleiotropic transactivator HBx, has also been associated with the development of HCC. In this study, we investigated whether nucleotide changes in the X gene of genotype C are associated with the development of HCC.

Methods/results: We sequenced the X gene in age- and sex-matched 39 HBV-infected patients with HCC and 36 HBV-infected patients without HCC. A novel nucleotide change that resulted in a proline to serine substitution at codon 38 in HBx (codon-38 change) was preferentially found in patients with HCC. Then, sera were collected from a new group of age- and sex-matched 52 patients with HCC and 51 patients without HCC. In this cohort also, the codon-38 change was associated with HCC. Multiple logistic regression analysis showed the prevalence of the codon-38 change was significantly associated with HCC in all patients (P=0.001, odds ratio: 4.89).

Conclusion: The codon-38 change in genotype C is an independent risk factor for the development of HCC and may serve as a useful molecular marker for predicting the clinical outcomes in patients infected with HBV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / pathology
  • Codon
  • DNA, Viral / genetics
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Hepatitis B / complications*
  • Hepatitis B / pathology
  • Hepatitis B / virology
  • Hepatitis B Antigens / immunology
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / immunology
  • Humans
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / pathology
  • Male
  • Middle Aged
  • Mutation*
  • Nucleotides / genetics*
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Risk Factors
  • Trans-Activators / genetics*
  • Viral Regulatory and Accessory Proteins

Substances

  • Codon
  • DNA, Viral
  • Hepatitis B Antigens
  • Nucleotides
  • Trans-Activators
  • Viral Regulatory and Accessory Proteins
  • hepatitis B virus X protein